We further found that the long form of VEGFR2 is the predominant mediator of VEGF-A in the pathogenesis of diabetic retinopathy (DR) and can be significantly inhibited by intravitreal steroid treatment. This evidence concerns the gene KDR and diabetic retinopathy.